Please select the option that best describes you:

Topics: Breast Cancer • Medical Oncology • Triple negative • Breast Cancer, Non-metastatic • Immune Checkpoint Inhibitor

Would you offer adjuvant AC + pembrolizumab for a triple negative breast cancer patient whose tumor progressed on carboplatin + paclitaxel + pembrolizumab on KEYNOTE-522 and required urgent surgery (ypT3 ypN0)? If not, would you lean towards adjuvant capecitabine?